Viking Therapeutics Inc (NASDAQ: VKTX) kicked off on Monday, down -2.41% from the previous trading day, before settling in for the closing price of $28.19. Over the past 52 weeks, VKTX has traded in a range of $18.92-$81.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -23.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -86.96%. With a float of $108.96 million, this company’s outstanding shares have now reached $112.29 million.
In an organization with 36 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Viking Therapeutics Inc (VKTX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 2.98%, while institutional ownership is 69.32%. The most recent insider transaction that took place on Jul 03 ’25, was worth 747,633. In this transaction President & CEO of this company sold 26,889 shares at a rate of $27.80, taking the stock ownership to the 2,388,014 shares. Before that another transaction happened on Jul 03 ’25, when Company’s Chief Financial Officer sold 4,266 for $27.76, making the entire transaction worth $118,428. This insider now owns 168,660 shares in total.
Viking Therapeutics Inc (VKTX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -86.96% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
Take a look at Viking Therapeutics Inc’s (VKTX) current performance indicators. Last quarter, stock had a quick ratio of 44.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -2.57 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Let’s dig in a bit further. During the last 5-days, its volume was 3.5 million. That was inferior than the volume of 4.12 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 80.09%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 49.17%, which indicates a significant decrease from 73.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.24% in the past 14 days, which was lower than the 76.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.35, while its 200-day Moving Average is $39.66. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $28.13. Second resistance stands at $28.76. The third major resistance level sits at $29.27. If the price goes on to break the first support level at $26.99, it is likely to go to the next support level at $26.48. The third support level lies at $25.85 if the price breaches the second support level.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
The company with the Market Capitalisation of 3.09 billion has total of 112,310K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -109,960 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -45,630 K.
